` MSB (Mesoblast Ltd) vs GILD (Gilead Sciences Inc) Comparison - Alpha Spread

MSB
vs
GILD

Over the past 12 months, MSB has underperformed GILD, delivering a return of +48% compared to the GILD's +71% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
MSB
GILD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

MSB Intrinsic Value
1.06 AUD
Overvaluation 35%
Intrinsic Value
Price
GILD Intrinsic Value
105.43 USD
Overvaluation 6%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Mesoblast Ltd
ASX:MSB
1.632 AUD
Gilead Sciences Inc
NASDAQ:GILD
111.75 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
MSB vs GILD

MSB
GILD
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Mesoblast Ltd
Revenue
Gilead Sciences Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
MSB vs GILD

MSB
GILD
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Mesoblast Ltd
ASX:MSB
Gilead Sciences Inc
NASDAQ:GILD
What is Free Cash Flow?

Gross Margin

MSB
201.8%
GILD
78.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

Operating Margin

MSB
-1 414.4%
GILD
38.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

Net Margin

MSB
-1 822.8%
GILD
20.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

FCF Margin

MSB
-753.5%
GILD
33.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

ROE

MSB
-21.3%
GILD
32.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

ROA

MSB
-15.6%
GILD
10.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

ROIC

MSB
-13.5%
GILD
19.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

ROCE

MSB
-13.2%
GILD
25.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Gilead Sciences Inc

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
MSB vs GILD

Loading

Performance Gap
MSB vs GILD

Loading
MSB
GILD
Difference
www.alphaspread.com

Performance By Year
MSB vs GILD

Loading
MSB
GILD
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare MSB to other stocks
Unlock Full Access to Alpha Spread
Create Free Account